KaydedilenlerDerginizi ekleyin

Dergiler / Turkish Journal of Gastroenterology / 2016 / Cilt: 27 - Sayı: 3

Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer

Sufang LİANG
Lin XU
Dongsheng ZHANG
Zhenjun WU
Sayfa
227–232
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Based on the preliminary intervention study, we conclude that probiotic intervention combats SIBO in patients with gastrointestinal cancer and alleviates its symptoms

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/Aims: Small intestinal bacterial overgrowth (SIBO) may be related to the presence of gastrointestinal cancer.
📊
Temel Bulgular & Veri:Materials and Methods: Employing a case-control design, 112 gastric and 88 colorectal cancer patients were evaluated.
💡
Sonuç & Katkı:Based on the preliminary intervention study, we conclude that probiotic intervention combats SIBO in patients with gastrointestinal cancer and alleviates its symptoms
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Background/Aims: Small intestinal bacterial overgrowth (SIBO) may be related to the presence of gastrointestinal cancer. The exact link, however, between SIBO and cancer prevalence as well as cancer symptoms remains unclear, especially in Asian populations. In addition, there is a paucity of data documenting the influence of probiotic treatment of SIBO on cancer symptoms. Here, the aims were to correlate the presence of SIBO with cancer prevalence and cancer symptoms, as well as to investigate the effect of probiotic intervention on SIBO and cancer symptoms. Materials and Methods: Employing a case-control design, 112 gastric and 88 colorectal cancer patients were evaluated. Questionnaires were used to assess gastrointestinal symptoms and a glucose-H2-breath test (GHBT) was used to determine SIBO status. Patients with SIBO were administered Bifidobacterium triple viable capsule therapy or placebo. Subsequently, SIBO status and gastrointestinal symptom scores were reanalyzed. Results: In our study group, 63.0% of patients versus 16.3% of controls was tested positive for SIBO. In patients with cancer, SIBO was associated with proton pump inhibitor (PPI) use. Bifidobacterium triple viable capsule was effective in combating SIBO and was associated with a significant improvement in gastrointestinal cancerrelated symptoms. Conclusion: In a Chinese cohort, SIBO is associated with gastrointestinal cancer. Based on the preliminary intervention study, we conclude that probiotic intervention combats SIBO in patients with gastrointestinal cancer and alleviates its symptoms

🔖

Bu Makaleye Atıf Yap

LİANG, S., XU, L., ZHANG, D., WU, Z. (2016). Effect of probiotics on small intestinal bacterial overgrowth in patients with gastric and colorectal cancer. Turkish Journal of Gastroenterology, Cilt: 27 - Sayı: 3, 227–232. https://ajindex.com/articles/411403

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (6)

  1. Ghoshal UC, Ghoshal U, Das K, Misra A. Utility of hydrogen breath tests in diagnosis of small intestinal bacterial overgrowth in mal- absorption syndrome and its relationship with oro-cecal transit time. Indian J Gastroenterol 2006; 25: 6-10.
  2. Konstantinov SR, Kuipers EJ, Peppelenbosch MP. Functional ge- nomic analyses of the gut microbiota for CRC screening. Nat Rev Gastroenterol Hepatol 2013; 10: 741-5. [CrossRef] Parracho H, McCartney AL, Gibson GR. Probiotics and prebiotics ininfant nutrition. Proc Nutr Soc 2007; 66: 405-11. [CrossRef] Posserud I, Stotzer PO, Björnsson ES, Abrahamsson H, Simrén M. Small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Gut 2007; 56: 802-8. [CrossRef] King T. Small intestinal bacterial overgrowth and irritable bowel syndrome. JAMA 2004; 292: 2213-4.
  3. Gasbarrini A, Lauritano EC, Gabrielli M, et al. Small intestinal bac- terial overgrowth: diagnosis and treatment. Dig Dis 2007; 25: 237- 40. [CrossRef] Saad RJ, Chey WD. Breath Testing for Small Intestinal Bacterial Overgrowth: Maximizing Test Accuracy. Clin Gastroenterol Hepa- tol 2013; S1542-3565: 1468-7.
  4. Pyleris E, Giamarellos-Bourboulis EJ, Tzivras D, Koussoulas V, Bar- batzas C, Pimentel M. The prevalence of overıgrowth by aerobic bacteria in the small intestine by small bowel culture: relation- ship with irritable bowel syndrome. Dig Dis Sci 2012; 57: 1321-9. [CrossRef] Schiller LR. Evaluation of small bowel bacterial overıgrowth. Curr Gastroenterol Rep 2007; 9: 373-7. [CrossRef] Rana SV, Sharma S, Kaur J, Sinha SK, Singh K. Comparing of lact- ulose and glucose breath test for diagnosis of small intestinal bacterial overgrowth in patients with irritable bowel syndrome. Digestion 2012; 85: 243-7. [CrossRef] Bures J, Cyrany J, Kohoutova D, et al. Small intestinal bacterial overgrowth syndrome. World J Gastroenterol 2010; 16: 2978-90. [CrossRef] Wang Xiaohui, Yan Zhihui, Li Chao, et al. Clinical effect compari- son between Bifidobaeterium triple viable capsules and Rifaxi- min onirritable bowel syndrome with small intestinal bacterial overgrowth. Acad J Chin PLA Med Sch 2015; 36: 970-2.
  5. He Xing, Wang Xiaohui, Yan Zhihui, et al. Efficacy of rifaximin and bifidobacterium triple viable capsules sequential therapy for smallintestinal bacterial overgrowth. Acad J Chin PLA Med Sch 2015; 36: 973-5.
  6. Choi YK, Kraft N, Zimmerman B, Jackson M, Rao SS. Fructose intol- erance in IBS and utility of fructose-restricted diet.J Clin Gastroen- terol 2008; 42: 233-8.